1. Home
  2. INTS vs VRME Comparison

INTS vs VRME Comparison

Compare INTS & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • VRME
  • Stock Information
  • Founded
  • INTS 2012
  • VRME 1999
  • Country
  • INTS United States
  • VRME United States
  • Employees
  • INTS N/A
  • VRME N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • VRME EDP Services
  • Sector
  • INTS Health Care
  • VRME Technology
  • Exchange
  • INTS Nasdaq
  • VRME Nasdaq
  • Market Cap
  • INTS 12.2M
  • VRME 10.0M
  • IPO Year
  • INTS 2023
  • VRME N/A
  • Fundamental
  • Price
  • INTS $0.31
  • VRME $1.01
  • Analyst Decision
  • INTS Strong Buy
  • VRME Strong Buy
  • Analyst Count
  • INTS 4
  • VRME 2
  • Target Price
  • INTS $4.50
  • VRME $1.50
  • AVG Volume (30 Days)
  • INTS 5.0M
  • VRME 1.0M
  • Earning Date
  • INTS 11-12-2025
  • VRME 11-11-2025
  • Dividend Yield
  • INTS N/A
  • VRME N/A
  • EPS Growth
  • INTS N/A
  • VRME N/A
  • EPS
  • INTS N/A
  • VRME N/A
  • Revenue
  • INTS N/A
  • VRME $22,071,000.00
  • Revenue This Year
  • INTS N/A
  • VRME N/A
  • Revenue Next Year
  • INTS N/A
  • VRME $5.98
  • P/E Ratio
  • INTS N/A
  • VRME N/A
  • Revenue Growth
  • INTS N/A
  • VRME N/A
  • 52 Week Low
  • INTS $0.19
  • VRME $0.55
  • 52 Week High
  • INTS $3.75
  • VRME $5.00
  • Technical
  • Relative Strength Index (RSI)
  • INTS 64.31
  • VRME 53.92
  • Support Level
  • INTS $0.27
  • VRME $0.85
  • Resistance Level
  • INTS $0.30
  • VRME $1.14
  • Average True Range (ATR)
  • INTS 0.03
  • VRME 0.08
  • MACD
  • INTS 0.01
  • VRME 0.01
  • Stochastic Oscillator
  • INTS 60.25
  • VRME 58.62

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

Share on Social Networks: